Neilsen PM - Search Results

1

Antioxidative and therapeutic potential of selected Australian plants: A review.

Mani JS, Johnson JB, Hosking H, Ashwath N, Walsh KB, Neilsen PM, Broszczak DA, Naiker M. Mani JS, et al. Among authors: neilsen pm. J Ethnopharmacol. 2021 Mar 25;268:113580. doi: 10.1016/j.jep.2020.113580. Epub 2020 Nov 13. J Ethnopharmacol. 2021. PMID: 33189842 Review.

2

Natural product-derived phytochemicals as potential agents against coronaviruses: A review.

Mani JS, Johnson JB, Steel JC, Broszczak DA, Neilsen PM, Walsh KB, Naiker M. Mani JS, et al. Among authors: neilsen pm. Virus Res. 2020 Jul 15;284:197989. doi: 10.1016/j.virusres.2020.197989. Epub 2020 Apr 30. Virus Res. 2020. PMID: 32360300 Free PMC article. Review.

3

P53 activation suppresses irinotecan metabolite SN-38-induced cell damage in non-malignant but not malignant epithelial colonic cells.

Gunasegaran B, Neilsen PM, Smid SD. Gunasegaran B, et al. Among authors: neilsen pm. Toxicol In Vitro. 2020 Sep;67:104908. doi: 10.1016/j.tiv.2020.104908. Epub 2020 Jun 2. Toxicol In Vitro. 2020. PMID: 32502622

4

Pre-activation of the p53 pathway through Nutlin-3a sensitises sarcomas to drozitumab therapy.

Pishas KI, Neuhaus SJ, Clayer MT, Adwal A, Brown MP, Evdokiou A, Callen DF, Neilsen PM. Pishas KI, et al. Among authors: neilsen pm. Oncol Rep. 2013 Jul;30(1):471-7. doi: 10.3892/or.2013.2454. Epub 2013 May 13. Oncol Rep. 2013. PMID: 23670273

5

A comparison of vitamin D activity in paired non-malignant and malignant human breast tissues.

Suetani RJ, Ho K, Jindal S, Manavis J, Neilsen PM, Pishas KI, Rippy E, Bochner M, Kollias J, Gill PG, Morris HA, Callen DF. Suetani RJ, et al. Among authors: neilsen pm. Mol Cell Endocrinol. 2012 Oct 15;362(1-2):202-10. doi: 10.1016/j.mce.2012.06.022. Epub 2012 Jun 29. Mol Cell Endocrinol. 2012. PMID: 22750718

6

Nutlin-3a is a potential therapeutic for ewing sarcoma.

Pishas KI, Al-Ejeh F, Zinonos I, Kumar R, Evdokiou A, Brown MP, Callen DF, Neilsen PM. Pishas KI, et al. Among authors: neilsen pm. Clin Cancer Res. 2011 Feb 1;17(3):494-504. doi: 10.1158/1078-0432.CCR-10-1587. Epub 2010 Nov 23. Clin Cancer Res. 2011. PMID: 21098696

7

Nasopharyngeal carcinoma among the Bidayuh of Sarawak, Malaysia: History and risk factors.

Linton RE, Daker M, Khoo AS, Choo DCY, Viljoen M, Neilsen PM. Linton RE, et al. Among authors: neilsen pm. Oncol Lett. 2021 Jul;22(1):514. doi: 10.3892/ol.2021.12775. Epub 2021 May 6. Oncol Lett. 2021. PMID: 33986874 Free PMC article. Review.

8

Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome.

Neilsen PM, Noll JE, Suetani RJ, Schulz RB, Al-Ejeh F, Evdokiou A, Lane DP, Callen DF. Neilsen PM, et al. Oncotarget. 2011 Dec;2(12):1203-17. doi: 10.18632/oncotarget.382. Oncotarget. 2011. PMID: 22203497 Free PMC article.

9

Mutant p53 drives invasion in breast tumors through up-regulation of miR-155.

Neilsen PM, Noll JE, Mattiske S, Bracken CP, Gregory PA, Schulz RB, Lim SP, Kumar R, Suetani RJ, Goodall GJ, Callen DF. Neilsen PM, et al. Oncogene. 2013 Jun 13;32(24):2992-3000. doi: 10.1038/onc.2012.305. Epub 2012 Jul 16. Oncogene. 2013. PMID: 22797073

10

Targeting the p53 Pathway in Ewing Sarcoma.

Neilsen PM, Pishas KI, Callen DF, Thomas DM. Neilsen PM, et al. Sarcoma. 2011;2011:746939. doi: 10.1155/2011/746939. Epub 2010 Dec 9. Sarcoma. 2011. PMID: 21197471 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page